Chances Congress will bolster price transparency in health care, crack down on pharmaceutical middlemen, or support those struggling with addiction are dwindling as lawmakers race to fund federal health agencies.
Skepticism is mounting that lawmakers will make good on their health policy agenda, particularly after last year’s historically unproductive congressional session packed with House Republican infighting.
“I don’t think the political machine is working right now in terms of trying to pass legislation, and that’s more of a commentary about what’s happening in the House of Representatives than Congress as a whole,” said Bobby Clark, a principal at Pyxis Partners ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.